approaches established direct evidence for P2Y 2 R involvement in neointimal hyperplasia. Specific anti-P2Y 2 R therapies may be used against restenosis and bypass graft failure.
Introduction
Neointimal hyperplasia is a key feature of early atherosclerosis and restenosis after angioplasty [1, 2] . Migration and proliferation of vascular smooth muscle cells (SMC) caused by injury are the underlying causes of intimal hyperplasia [3] . In experimental intimal hyperplasia, an influx of leukocytes precedes the migration of SMC to the intima [4] . Studies have shown that blockade of mononuclear leukocyte influx but not that of polymorphonuclear leukocytes prevent intimal accumulation of SMC in the collar model of injury [4, 5] , thus excluding neutrophils as initiators of the migration of SMC into the intima. Mononuclear cells have been shown to induce cytokine expression, vascular SMC proliferation, and arterial occlusion after endothelial injury [6] . Increases in tumor necrosis factor (TNF)-α levels precede the migration of SMC into the intima in the balloon-injured rat aorta [7] . More direct evidence for TNF-α involvement in intimal hyperplasia has been also established [8] .
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Abstract
Objectives: Extracellular nucleotide release at the site of arterial injury mediates the proliferation and migration of vascular smooth muscle cells. Our aim was to investigate the role of the P2Y 2 nucleotide receptor (P2Y 2 R) in neointimal hyperplasia. Approach and Results: Vascular injury was induced by the implantation of a polyethylene cuff around the femoral artery in wild-type and P2Y 2 R-deficient mice (P2Y 2 R -/-). Electron microscopy was used to analyze monocyte and lymphocyte influx to the intima 36 h after injury. Compared to wild-type littermates, P2Y 2 R -/-mice exhibited a 3-fold decreased number of mononuclear leukocytes invading the intima (p < 0.05). Concomitantly, the migration of smooth muscle cells was decreased by more than 60% (p < 0.05), resulting in a sharp inhibition of intimal thickening formation in P2Y 2 R -/-mice (n = 15) 14 days after cuff placement. In vitro, loss of P2Y 2 R significantly impaired monocyte migration in response to nucleotide agonists. Furthermore, transgenic rats overexpressing the P2Y 2 R developed accelerated intimal lesions resulting in more than 95% luminal stenosis (p < 0.05, n = 10). Conclusions: Loss-and gain-of-function Similar to cytokines, alterations in extracellular nucleotide concentrations in response to vascular stress conditions have been documented. Extracellular nucleotides are released in the vascular wall from perivascular nerves, activated platelets, and mechanically stretched cells [9] [10] [11] [12] . Extracellular nucleotides induce both the proliferation and migration of vascular SMC [13] [14] [15] [16] [17] [18] [19] . Mice deficient in CD39, the ectoenzyme which is mainly responsible for nucleotides degradation in vascular SMC, exhibit reduced intimal thickening in response to vascular injury [20] . Upregulation and activation of the P2Y 2 nucleotide receptor (P2Y 2 R) subtype has been shown to stimulate neointimal growth in the collared rabbit carotid artery [21] . In this model, local uridine 5 ′ -triphosphate (UTP) delivery induced intimal accumulation of monocytes. In addition, nucleotide binding to P2Y 2 R stimulates the expression of vascular cell adhesion molecule-1, which suggests a role for UTP in early of leukocyte infiltration during vascular injury. However, the contribution of extracellular nucleotides and their receptors to intimal hyperplasia is still unclear.
Our aim was to establish a cause-and-effect relationship with respect to P2Y 2 R activation and neointimal hyperplasia. We used loss-and gain-of-function approaches to show that the P2Y 2 R regulates early mononuclear lymphocyte influx to the intima in the cuff model of femoral artery injury. We demonstrated that mice lacking the P2Y 2 R develop less neointimal area following arterial injury, whereas overexpression of the P2Y 2 R led to the formation of accelerated intimal thickening in rats. These data unequivocally provide direct evidence for P2Y 2 R involvement in neointimal hyperplasia, setting the stage for anti-P2Y 2 R therapies against graft failure and postangioplasty restenosis.
Methods
Animals
Eight-week-old wild-type and transgenic rats (Sprague-Dawley; Harlan, Indianapolis, IN, USA) were used in this study. Transgenic rats overexpressing the P2Y 2 R were produced as previously described using a lentiviral vector system and bred for 10 generations to ensure the stability of the transgene [22] . Wild-type and P2Y 2 R-deficient (P2Y 2 R -/-) mice (C57BL/6) were purchased from Jackson laboratory and used at 8 weeks of age. The animal protocols were approved by the University of Missouri Animal Care and Use Committee.
Femoral Artery Cuff Placement
Animals were anesthetized with ketamine (70 mg/kg) and xylazine (4 mg/kg) by intraperitoneal injection. The right femoral artery of the mouse was isolated from the surrounding tissues. A polyethylene cuff made of PE-50 tubing (inner diameter 0.56 mm, outer diameter 0.965 mm; Becton Dickinson, Mountain View, CA, USA) was cut longitudinally to open the tube, loosely placed around the artery and closed with a suture. The cuff was larger than the vessel meaning that blood flow was not obstructed. After the experimental period, the mice were killed by an overdose of the anesthesia. The cuffed artery was removed and microdissected from the cuff.
Tissue Harvesting and Histologic Staining
After sacrifice, femoral arteries were fixed in situ by constant pressure fixation at 100 mm Hg with 10% formalin using a 22-gauge butterfly catheter placed in the left ventricle of the heart. Cuffed and sham-operated femoral arteries were then embedded in paraffin. Cross-sections (5 μm thick) were continuously cut from one edge to the other edge of the cuffed and the control femoral arteries and mounted in order on five series of slides. Cross-sections were then stained with elastica van Gieson, hematoxylin and eosin or used for immunohistochemistry.
Morphometry
Hematoxylin and eosin-stained cross-sections were used for morphometric analysis. For this purpose, serial cross-sections (5 μm thick) were obtained every 75 μm throughout the entire length of the cuffed mouse femoral artery. To quantify intimal thickening, 5 equally spaced cross-sections in each animal were photographed, and the images were digitized. The areas of the neointima, the media, and the adventitia were measured using an image analyzing software (NIH image) by an observer blinded to the animal genotype or the treatment. The neointima was defined as the area between the vessel lumen and the internal elastic lamina. Media was defined as the area between the internal and external elastic lamina. The adventitia was defined as the area outside the external elastic lamina.
Incorporation and Detection of 5-Bromo-2 ′ -Deoxyuridine (BrdU)
Mice were injected intraperitoneally with 5-bromo-2 ′ -deoxyuridine (BrdU; 25 mg/kg; Sigma) 3, 2, and 1 day before euthanasia. Immunohistochemistry was performed using anti-BrdU antibody following the manufacturer's instructions (Zymed Laboratories). The number of BrdU-positive nuclei were counted in 5 cross-sections and expressed as a percentage of the total number of nuclei.
Electron Microscopy
Femoral arteries were removed from the cuff at the end of the experimental period and processed for transmission electron microscopy as previously described [5] . Ultrathin sections were collected on 75-mesh copper grids, stained with lead citrate, and examined with a Zeiss EM 10. Intimal cells (monocytes, lymphocytes, neutrophils, basophils, and eosinophils) and SMC were identified on the basis of their ultrastructural features as previously reported [5] . The number of intimal cells beneath the endothelium were determined for each cell type and expressed in relation to the number of endothelial cells overlying the lesion as previously described [5] .
Monocyte Migration Assay
Monocytes were isolated from mouse blood using the Easy- according to the manufacturer's instructions. Cell migration assay was performed in a 48-well chemotaxis chamber (Neuro Probe Inc., Bethesda, MD, USA) using polyvinylpyrrolidone-free polycarbonate filters with 5-μm diameter pores. The lower chamber contained RPMI 1640 medium in the presence or absence (negative control) of stimulus, and the upper chamber contained the cell suspension (2 × 10 6 cells/ml). The chemoattractant peptide N -formyl-methionyl-leucyl-phenylalanine (fMLP) served as a positive control. The chamber was incubated for 1 h at 37 ° C in air containing 5% CO 2. At the end of the experiment cells that had migrated were stained with hematoxylin. The number of migrated cells was determined after subtracting nonspecific migration (negative control).
Statistical Analyses
Data are presented as the mean ± SEM. Statistical analysis was performed with GraphPad Prism using either two-tailed the unpaired Student t test or one-way analysis of variance (ANOVA) followed by post hoc comparison. Differences with p values <0.05 were considered significant.
Results
P2Y 2 R-Deficiency Reduces Neointimal Hyperplasia
To establish a cause-effect link between P2Y 2 R and intimal hyperplasia, we subjected wild-type (n = 15) and P2Y 2 R -/-mice (n = 15) to cuff-induced injury of the femoral artery. We examined intimal lesion formation 14 days after injury, the time corresponding to a peak accumulation of SMC. Figure 1 a shows representative crosssections of the cuffed femoral arteries. Neointimal hyperplasia was uniformly distributed across the arterial lumen. P2Y 2 R -/-mice developed 7-fold less neointimal area than their corresponding wild-type littermates ( fig. 1 b) . Sham-operated arteries did not exhibit neointimal thickening ( fig. 1 b) . A comparison of intima-to-media ratios confirmed the reduction in neointimal size observed in P2Y 2 R -/-mice ( fig. 1 c) . The mean percent luminal stenosis was significantly higher in WT compared to P2Y 2 R -/-mice ( fig. 1 d) . Cell proliferation as assessed by BrdU incorporation into SMC 4 days after cuff placement was significantly suppressed in P2Y 2 R -/-mice ( fig. 1 e) . Intimal thickening in both groups was mainly composed of SM actin-positive cells ( fig. 1 f) .
P2Y 2 R Deletion Inhibits Mononuclear Lymphocyte Influx to the Intima
Mononuclear leukocytes (monocytes and lymphocytes), not neutrophils, mediate the subsequent migration of medial SMC to the intima following arterial injury [4, 5] . We next asked if deletion of the P2Y 2 R affects the influx of mononuclear leukocytes to arteries following arterial injury. Electron microscopy has been used to distinguish granulocytes (i.e. neutrophils, basophils, and eosinophils) from monocytes and lymphocytes by their specific granules [5] . Because this method cannot always sharply distinguish between monocytes and lymphocytes, we grouped lymphocytes and monocytes as mononuclear leukocytes, as has been done previously [5] . In wild-type mice, a significant number of mononuclear lymphocytes invaded the nascent intimal thickening 36 h following cuff implantation ( fig. 2 a) . Notably, mononuclear lymphocytes influx after cuff placement was significantly suppressed in P2Y 2 R -/-mice ( fig. 2 a) . These data clearly show that an absence of P2Y 2 R blocks the influx of monocytes and lymphocytes during arterial injury.
Loss of P2Y 2 R Inhibits SMC Migration
As previously reported in the cuff model of injury, SMC migration is the dominant factor contributing to the early accumulation of SMC in the nascent intima [4] . We and others have shown that extracellular nucleotides acting through P2Y 2 R regulate SMC migration [18, 19, 23] . Therefore, we asked if deletion of P2Y 2 R influences the migration of medial SMC to the intima. We identified SMC on the basis of their ultrastructural features using electron microscopy, and determined their number by quantitative analysis of ultrathin sections. SMC started to migrate from the underlying media into the intimal compartment 36 h following cuff implantation. At this time point, the number of SMC that invaded the intima in P2Y 2 R -/-mice was strikingly lower as compared to wild-type littermates ( fig. 2 b) . In contrast, no SMC was detectable in the intima in sham-operated arteries from either genotype ( fig. 2 b) . These data demonstrate that loss of P2Y 2 R inhibits early migration of SMC to the intima.
Extracellular Nucleotides Acting through P2Y 2 R Promote Monocyte Migration
To elucidate the mechanism by which P2Y 2 R regulates mononuclear leukocyte influx, we tested whether P2Y 2 R agonists promote monocyte migration. Using a chemotaxis assay, we found that UTPγS, a slowly hydrolysable analog of the P2Y 2 R, promotes the migration of monocytes from wild-type mice in a dose-dependent manner ( fig. 3 ). In contrast, P2Y 2 R deficiency significantly impaired monocyte migration in response to UTPγS ( fig. 3 ). Adenosine triphosphate (ATP), another potent agonist of the P2Y 2 R, also induced the migration of monocytes from wild-type but not from P2Y 2 R -/-mice (data not shown), confirming the involvement of P2Y 2 R in monocyte mi- 
Overexpression of P2Y 2 R Accelerates Neointimal Hyperplasia
We generated the first transgenic rat overexpressing a purinergic receptor [22] . We next used this gain-of-function approach to test if the overexpression of P2Y 2 R promotes neointimal hyperplasia. Wild-type and P2Y 2 R transgenic rats were subjected to femoral artery injury and intimal lesions were assessed on day 14. Wild-type animals developed a modest intimal thickening ( fig. 4 a,  b) consisting of α-SMC actin-positive cells (data not shown). Rats overexpressing the P2Y 2 R transgene exhibited a dramatic increase in neointimal area compared to their wild-type littermates ( fig. 4 a, b) , whereas sham-operated arteries did not exhibit intimal thickening ( fig. 4 b) . There was no significant difference in the medial area between wild-type and transgenic rats. As expected, the intima/media ratio was greater in the transgenic rats compared to wild-type controls ( fig. 4 c) . The mean percent luminal stenosis in the transgenic rats was over 95% (p < 0.001; fig. 4 d) , resulting in near blockade of the arterial lumen. These results further confirm that the P2Y 2 R is involved in neointimal hyperplasia. 
Discussion
Several lines of evidence support a role for extracellular nucleotides in the response to vascular injury. We first reported that P2Y 2 R is overexpressed in intimal lesions of the rat carotid artery [23] . In addition, the local delivery of nucleotides via a miniosmotic pump to the collared rabbit carotid artery accelerates the development of intimal hyperplasia [21] . Furthermore, mice deficient in CD39 (the ectoenzyme which is mainly responsible for nucleotides degradation) exhibit reduced intimal thickening in response to vascular injury [20] , thus confirming the crucial role of extracellular nucleotides in the development of intimal hyperplasia. However, given that purinergic receptors are ubiquitously expressed in vascular cells, it was necessary to determine if the P2Y 2 R is directly involved in the vascular response to injury. In this study, we used lossand gain-of-function approaches to directly assess the contribution of P2Y 2 R to neointimal hyperplasia. We demonstrated that P2Y 2 R deficiency decreased the neointimal area induced by the placement of a cuff around the mouse femoral artery. Conversely, overexpression of P2Y 2 R in rats accelerated neointimal hyperplasia, resulting in near complete arterial luminal stenosis. The P2Y 2 R is expressed in virtually all blood-derived cells [12] . It was reported that blockade of mononuclear leukocyte influx but not that of neutrophils decreased the intimal accumulation of SMC in the femoral artery cuff model of vascular injury [4, 5] , thus excluding neutrophils as initiators of the migration of SMC into the intima. Activation of P2Y 2 R stimulates monocyte recruitment in the collared rabbit carotid artery [21] . Mechanistically, we found that the absence of P2Y 2 R significantly impaired mononuclear lymphocyte influx to the intima. In addition, monocytes lacking P2Y 2 R failed to migrate in response to nucleotide agonists, demonstrating the importance of monocyte P2Y 2 R in the early response to vascular injury. Stimulation of P2 receptors is coupled to the release of the proinflammatory cytokine interleukins [24] [25] [26] [27] that are of obvious relevance to the development of neointimal hyperplasia. We showed that P2Y 2 R activation regulates the secretion of lymphotoxin-α (a member of the TNF ligand family) in murine monocytes [28] . Interestingly, ApoE − / − mice deficient in P2Y 2 R exhibit a decreased production of lymphotoxin-α and delayed onset of atherosclerosis. Furthermore, the administration of lymphotoxin-α neutralizing antibody also prevents lesion formation in ApoE − / − mice [29] . These data suggest that monocyte P2Y 2 R contributes to neointimal hyperplasia at least by modulating the secretion of cytokines that directly stimulate SMC proliferation. Ectoenzymes that metabolize ATP play important roles in regulating the response to endothelial dysfunction. In many cell types, including endothelial cells, nucleoside triphosphate diphosphohydrolase-1/CD39 and ecto-5 ′ -nucleotidase/CD73 dephosphorylate ATP and ADP to AMP. AMP is then converted to adenosine by CD73 or other enzymes. The importance of this extracellular purinergic flux in controlling inflammation is apparent in mice genetically engineered to lack CD39 [30, 31] . In these animals, the activation of inflammatory cells, such as platelets, macrophages, and neutrophils, and their adhesion to the vascular endothelium are enhanced. Mice deficient in CD39 exhibit reduced intimal thickening in response to vascular injury [20] . The P2Y 2 R is distinguished among G protein-coupled receptors in its ability to interact directly with growth factor receptors to transactivate their signal transduction pathways. For example, we have shown the importance of P2Y 2 R interaction with vascular endothelial cell growth factor receptor (VEGFR-2) in the regulation of VCAM-1 expression [32] . Since VCAM-1 plays a crucial role in both atherosclerosis and neointimal hyperplasia, targeted control of endothelial P2Y 2 R could prevent intimal hyperplasia that accompanies these processes.
Extracellular nucleotides acting via G protein-coupled P2Y receptors serve as potent stimulators for the migration of SMC in vitro [18, 19] . Here, we demonstrated that P2Y 2 R deficiency prevents the early migration of SMC to the intima in response to cuff-induced injury. ATP stimulates the release of matrix metalloproteinase-2 (MMP-2) from human aortic SMC [33] , and MMP-2-induced matrix degradation facilitates the migration and proliferation of SMC [34] . Interestingly, both ATP and UTP are potent chemotactic agents that stimulate VSMC migration via P2Y 2 R [18, 19] . We have shown that P2Y 2 R interacts with the actin-binding protein filamin A to mediate SMC migration [35] . Altogether, these mechanisms may explain our findings that perivascular infusion of UTP into the collared rabbit carotid arteries enhanced neointimal development [21] and P2Y 2 R expression is associated with coronary in-stent restenosis [36] . Abundant sources for extracellular ATP in the vessel and the trophic effects on vascular SMC suggest that SMC P2Y 2 R might contribute to intimal hyperplasia by stimulating the proliferation of vascular SMC. In support of this idea, a significant number of BrdU-positive SMC were detected in the cuffed artery of wild-type mice. In contrast, the percentage of proliferating cells was strikingly lower in P2Y 2 R -/-mice. Subsequently, we found that wild-type mice exhibited 7-fold more neointimal area compared to P2Y 2 R -/-mice. Furthermore, overexpression of the P2Y 2 R drastically increased intimal hyperplasia, causing a near complete blockade of the arterial lumen only 14 days after injury. Thus, we conclude that P2Y 2 R contributes to neointimal hyperplasia by stimulating both the migration proliferation of vascular SMC.
In summary, as depicted in figure 5 , we demonstrated that P2Y 2 R directly regulates the influx of mononuclear lymphocytes that are essential for the subsequent migration and accumulation of SMC into the neointima. Therefore, this nucleotide receptor might be a therapeutic target for the prevention of graft failure and postangioplasty restenosis.
